The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open-label, phase Ib study of NEO-PV-01 + adjuvant with nivolumab in patients with melanoma, non-small cell lung carcinoma, or transitional cell carcinoma of the bladder.
 
Aung Naing
Research Funding - Amplimmune; ARMO BioSciences; Atterocor; Baxter (I); EMD Serono; Healios; Incyte; Karyopharm Therapeutics; MedImmune; NCI; Novartis; Regeneron
Travel, Accommodations, Expenses - ARMO BioSciences
 
Siwen Hu-Lieskovan
Honoraria - Amgen; Emergent BioSolutions; Merck; Novartis; Vaccinex
Consulting or Advisory Role - Amgen; Emergent BioSolutions; Merck; Novartis; Vaccinex
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Neon Therapeutics (Inst); Pfizer (Inst); Plexxikon (Inst)
 
Ramaswamy Govindan
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Abbvie; Bayer; Boehringer Ingelheim; Celgene; Clovis Oncology; Genentech/Roche; GlaxoSmithKline; Helsinn Therapeutics; Novartis
Research Funding - Abbvie (Inst); Bayer (Inst); GlaxoSmithKline (Inst); MethylGene (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Celgene; Genentech; GlaxoSmithKline; Merck
 
Kim Allyson Margolin
Consulting or Advisory Role - Inanovate; Lion Biotechnologies; Pfizer
Research Funding - Altor Bioscience; Merck
 
Melissa Ann Moles
Employment - Neon Therapeutics; Novartis
Stock and Other Ownership Interests - Neon Therapeutics; Novartis
 
Richard Gaynor
Employment - Lilly
Leadership - Lilly
Stock and Other Ownership Interests - Lilly
Travel, Accommodations, Expenses - Lilly
 
Matthew Jordan Goldstein
Employment - Neon Therapeutics
Stock and Other Ownership Interests - Neon Therapeutics
Consulting or Advisory Role - Tango Therapeutics
Patents, Royalties, Other Intellectual Property - Neon Therapeutics
 
Patrick Alexander Ott
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; Bristol-Myers Squibb; Celldex; CytomX Therapeutics; Genentech; Neon Therapeutics
Research Funding - ARMO BioSciences (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Merck (Inst)